Under the deal, $725 million will be paid at closing and $125 million will be paid in January 2012. To fund the transaction, MedAssets has obtained financing commitments from
MedAssets expects to achieve at least $20 million of expense-based synergies in 2011. When combined with the growth of both businesses, the company expects this transaction to be about 5 cents to 10 cents accretive to non-GAAP diluted cash earnings a share in 2011.
Together, MedAssets and Broadlane would have reported non-GAAP combined net revenue of $508.9 million and non-GAAP combined adjusted earnings before interest, taxes, depreciation and amortization of $161.8 million for the year ended Dec. 31, 2009.
Patrick Ryan, chairman and CEO of Broadlane, is expected to join the MedAssets' board and assume the role of president of the company's spend management segment upon completion of the transaction.
-- Written by Andrea Tse in New York.
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.